GO:0106354 tRNA surveillance: Quality Control Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106354 tRNA surveillance is the biological process that identifies and degrades defective or aberrant tRNAs, protecting translation fidelity.
• tRNA surveillance is mechanistically linked to amino acid availability and higher-order tRNA-mRNA interactions that sense codon-anticodon pairing quality.
• Defective tRNA processing and modification can generate tRNA-derived fragments (tRFs) and tsRNAs that are genetically controlled and contribute to cancer risk.
• tRNA modifications such as m1A (TRMT6/TRMT61A) act as translational checkpoints, and their dysregulation promotes colorectal cancer progression.
• tRNA surveillance intersects with epigenetic inheritance, as sperm-borne mitochondrial RNAs can transmit diet-induced metabolic phenotypes.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of tRNA surveillance genes in disease.
Description
tRNA surveillance (GO:0106354) is the set of cellular processes that identify and degrade defective or aberrant tRNAs, thereby maintaining the integrity of the translational machinery. Because tRNAs are the adaptor molecules that decode mRNA into protein, their quality control is fundamental to proteome fidelity and cellular homeostasis. Defects in tRNA surveillance can lead to accumulation of faulty tRNAs, impaired amino acid surveillance, and activation of stress responses that contribute to human disease. Recent studies have shown that tRNA-derived fragments (tRFs) and tRNA-derived small RNAs (tsRNAs) are not merely degradation products but biologically active molecules with roles in cancer, epigenetic inheritance, and neurological disease. Understanding tRNA surveillance therefore requires integrating structural biology, RNA modification enzymology, and functional genomics. This article provides a research-grade overview of GO:0106354, its molecular players, disease connections, and the CRISPR-based methods used to study it.
tRNA surveillance At A Glance
| GO ID | GO:0106354 |
|---|---|
| GO term | tRNA surveillance |
| Ontology | biological_process |
| Synonym | None listed |
| Definition | The set of processes involved in identifying and degrading defective or aberrant tRNAs. |
| Major function | Quality control of tRNA molecules to maintain translation fidelity |
| Related processes | tRNA modification, tRNA processing, amino acid surveillance, tRNA-derived fragment biogenesis |
| Disease relevance | Cancer, metabolic disorders, neurological disease, epigenetic inheritance |
| Key experimental approaches | CRISPR knockout/knock-in, RNA-seq, Ribo-seq, tRNA modification profiling |
What Is GO:0106354?
According to the Gene Ontology, tRNA surveillance (GO:0106354) is defined as the set of processes involved in identifying and degrading defective or aberrant tRNAs. In practice, this includes recognition of structurally or chemically abnormal tRNA species, their targeting to degradation pathways, and the downstream consequences for translation and cellular stress responses. The term is a biological process and has no synonyms in the current QuickGO release.
Why Is tRNA surveillance Important in Cell Biology?
tRNA surveillance is critical because aberrant tRNAs can cause mistranslation, proteotoxic stress, and activation of integrated stress responses that drive disease. The process is also a source of regulatory small RNAs, including tRFs and tsRNAs, which have been implicated in cancer risk and precision therapy. Moreover, tRNA surveillance intersects with epigenetic inheritance, as sperm-borne mitochondrial RNAs can transmit diet-induced phenotypes across generations. Understanding this pathway offers opportunities for therapeutic intervention in cancer, metabolic disorders, and neurodegeneration.
• Maintains translation fidelity by eliminating defective tRNAs.
• Links amino acid availability to translational control through higher-order tRNA-mRNA interactions.
• Generates tRNA-derived fragments (tRFs) and tsRNAs with regulatory functions.
• tRNA modifications such as m1A act as translational checkpoints in cancer.
• Dysregulation contributes to colorectal cancer progression via histone synthesis control.
• Genetic control of tRNA-derived fragments influences cancer risk.
• tsRNA-defined molecular subtypes guide precision therapy in gastric cancer.
• Sperm-borne mitochondrial RNAs mediate epigenetic inheritance of diet-induced traits.
• Provides biomarkers for liquid biopsy in neurological diseases.
• Offers targets for CRISPR-based functional validation and therapeutic development.
What Happens During tRNA surveillance?
Recognition of aberrant tRNA structures
In simple terms: The cell first detects that a tRNA molecule is malformed or chemically incorrect.
tRNA surveillance begins with the recognition of defective or aberrant tRNA species. Structural studies have revealed that higher-order tRNA-mRNA interactions mediate amino acid surveillance, allowing the translation machinery to sense codon-anticodon pairing quality. This quality-control step ensures that only properly folded and modified tRNAs participate in translation, while aberrant species are targeted for degradation.
tRNA modification as a surveillance checkpoint
In simple terms: Chemical tags on tRNA act like quality stamps; missing or wrong tags mark the tRNA for destruction.
tRNA modifications are essential for tRNA stability and function, and their absence can trigger surveillance. For example, TRMT6-mediated tRNA m1A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression. This demonstrates that tRNA modification enzymes are integral to surveillance pathways that monitor tRNA integrity and regulate downstream gene expression.
Degradation of defective tRNAs and generation of tRNA-derived fragments
In simple terms: Once a tRNA is flagged as defective, it is cut into small pieces called tRNA-derived fragments.
Defective tRNAs are degraded by cellular nucleases, producing tRNA-derived fragments (tRFs) and tRNA-derived small RNAs (tsRNAs). Genetic control of tRNA-derived fragments contributes to cancer risk, indicating that the degradation step is genetically regulated and functionally important. These fragments are not merely waste products; they can regulate gene expression and serve as biomarkers.
Integration with amino acid sensing and stress responses
In simple terms: tRNA surveillance is wired into the cell's nutrient-sensing networks, so it responds to amino acid levels.
tRNA surveillance is coupled to amino acid availability through higher-order tRNA-mRNA interactions that sense the charging status of tRNAs. When amino acids are limiting, uncharged tRNAs can trigger stress responses that intersect with surveillance pathways. This integration ensures that translation is adjusted to metabolic conditions and that defective tRNAs are cleared under stress.
Epigenetic inheritance via sperm-borne mitochondrial RNAs
In simple terms: Small RNAs from mitochondria in sperm can carry dietary information to offspring, linking tRNA surveillance to inheritance.
Recent evidence shows that epigenetic inheritance of diet-induced and sperm-borne mitochondrial RNAs involves small RNA pathways that overlap with tRNA surveillance machinery. This suggests that tRNA surveillance processes can influence transgenerational phenotypes, expanding its biological significance beyond cell-autonomous quality control.
Key Genes Involved in GO:0106354 tRNA surveillance
The following genes and proteins are experimentally implicated in tRNA surveillance, tRNA modification, and tRNA-derived fragment biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRMT6 | tRNA m1A modification enzyme subunit | Translational checkpoint of histone synthesis; colorectal cancer progression |
| TRMT61A | tRNA m1A modification enzyme subunit | Part of TRMT6/TRMT61A complex; cancer metabolism |
| ANG | Ribonuclease producing tRNA-derived fragments | Generates tRFs/tsRNAs; cancer and neurological disease |
| DICER1 | RNase III processing small RNAs | tRNA-derived fragment biogenesis; cancer risk |
| AGO2 | Argonaute effector protein | tsRNA-mediated gene silencing; cancer |
| METTL1 | tRNA m7G methyltransferase | tRNA modification and stability; cancer |
| WDR4 | METTL1 cofactor | tRNA m7G modification; cancer risk |
| NSUN2 | tRNA m5C methyltransferase | tRNA stability and surveillance; cancer |
| PUS7 | Pseudouridine synthase | tRNA modification; stem cell function |
| DKC1 | Pseudouridine synthase | tRNA modification; ribosomopathy |
| ELAC2 | tRNA 3' processing endonuclease | tRNA maturation and surveillance |
| TRMT10A | tRNA methyltransferase | tRNA modification; metabolic disease |
| CLP1 | tRNA splicing kinase | tRNA processing; neurodegeneration |
| TSEN54 | tRNA splicing endonuclease subunit | tRNA maturation; pontocerebellar hypoplasia |
| RTCB | tRNA ligase | tRNA splicing; stress response |
| TRMT2A | tRNA methyltransferase | tRNA modification; cancer |
| FTSJ1 | tRNA methyltransferase | tRNA modification; intellectual disability |
| TRMT1 | tRNA methyltransferase | tRNA modification; neurological disease |
How Is tRNA surveillance Regulated?
tRNA surveillance is regulated at multiple levels, including tRNA modification enzymes, amino acid availability, and stress-responsive signaling. TRMT6-mediated m1A modification acts as a translational checkpoint that couples tRNA surveillance to histone synthesis and cancer progression. Higher-order tRNA-mRNA interactions provide a structural basis for amino acid surveillance, allowing the translation machinery to monitor tRNA charging status. Additionally, genetic control of tRNA-derived fragments suggests that specific loci regulate the production of these small RNAs in response to cellular conditions. Sperm-borne mitochondrial RNAs further indicate that tRNA surveillance can be epigenetically regulated across generations.
tRNA surveillance and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRMT6 | Colorectal cancer progression | Knockout and overexpression in HCT116 cells |
| ANG | Cancer and neurological disease | Knockout in HeLa and neuronal cells |
| CLP1 | Neurodegeneration | Knock-in of patient mutations in iPSC-derived neurons |
| TSEN54 | Pontocerebellar hypoplasia | Knockout in mouse models |
| DICER1 | Cancer risk | Conditional knockout in mouse models |
tRNA surveillance in cancer
Dysregulation of tRNA surveillance and tRNA modification promotes cancer progression. TRMT6-mediated tRNA m1A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression. Genetic control of tRNA-derived fragments contributes to cancer risk, and tsRNA-defined molecular subtypes guide precision therapy in gastric cancer. These findings position tRNA surveillance components as potential biomarkers and therapeutic targets.
tRNA surveillance in neurological disease
tRNA-derived fragments and tsRNAs are detectable in liquid biopsy and have been associated with neurological diseases. Mutations in tRNA processing and modification enzymes, such as CLP1 and TSEN54, cause neurodegeneration and pontocerebellar hypoplasia, highlighting the importance of tRNA surveillance in neuronal survival. The presence of tRNA fragments in biofluids offers opportunities for non-invasive diagnostics.
tRNA surveillance in metabolic and epigenetic inheritance
Sperm-borne mitochondrial RNAs mediate epigenetic inheritance of diet-induced traits, linking tRNA surveillance to metabolic programming across generations. This suggests that environmental factors can alter tRNA surveillance pathways, with lasting effects on offspring metabolism.
From tRNA surveillance-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TRMT6 loss affect tRNA m1A and histone synthesis? | TRMT6 knockout cell line |
| Does a point mutation in a tRNA modification enzyme alter surveillance? | Point-mutation knock-in via CRISPR |
| Can a tagged tRNA surveillance protein be tracked in live cells? | Tagged knock-in (e.g., GFP) |
| Does overexpression of ANG increase tRNA-derived fragments? | Overexpression cell line |
| Which genes regulate tRNA-derived fragment production? | CRISPR library screening |
| Does a disease-associated mutation in CLP1 impair tRNA splicing? | Knock-in mouse model |
How to Study the tRNA surveillance Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript abundance and tRNA fragment levels | Cancer subtype classification |
| Small RNA-seq | tRNA-derived small RNA profiles | Biomarker discovery |
| Ribo-seq | Translation efficiency and codon occupancy | tRNA modification checkpoint studies |
| Mass spectrometry | tRNA modification stoichiometry | Enzyme function validation |
| CRISPR knockout | Gene loss-of-function phenotypes | Causal gene discovery |
| Base editing | Precise point mutations | Disease variant modeling |
| Liquid biopsy | Circulating tRNA fragments | Neurological disease diagnostics |
RNA sequencing and tRNA fragment profiling
RNA-seq and small RNA-seq are used to quantify tRNA-derived fragments and tsRNAs. Genetic control of tRNA-derived fragments has been mapped using these approaches, revealing contributions to cancer risk. tsRNA-defined molecular subtypes in gastric cancer were identified through transcriptomic profiling, demonstrating the utility of RNA-seq in tRNA surveillance research.
Ribosome profiling (Ribo-seq)
Ribo-seq measures translation at codon resolution and can reveal defects in tRNA surveillance. TRMT6-mediated m1A modification acts as a translational checkpoint of histone synthesis, a finding supported by ribosome profiling. This method is essential for linking tRNA surveillance to translation efficiency.
tRNA modification profiling
Mass spectrometry and sequencing-based methods detect tRNA modifications such as m1A, m7G, and m5C. These approaches have been used to show that TRMT6/TRMT61A catalyze m1A and that loss of this modification affects translation. Modification profiling is critical for understanding how chemical marks regulate tRNA surveillance.
CRISPR-based functional genomics
CRISPR knockout, point-mutation, and knock-in models enable causal testing of tRNA surveillance genes. DNA capture by a CRISPR-Cas9-guided adenine base editor has been structurally characterized, providing a framework for precise editing of tRNA modification enzymes. These tools are used to dissect the roles of genes such as TRMT6 and ANG in disease models.
How CRISPR Can Be Used to Study GO:0106354 tRNA surveillance
Knockout
CRISPR knockout is used to eliminate tRNA surveillance genes such as TRMT6 or ANG, revealing their roles in tRNA modification, fragment production, and cancer progression. Knockout cell lines are essential for validating loss-of-function phenotypes observed in patient samples.
Point Mutation
CRISPR base editors and prime editors introduce precise point mutations to model disease-associated variants in tRNA surveillance genes. DNA capture by a CRISPR-Cas9-guided adenine base editor has been structurally resolved, enabling accurate editing of enzyme active sites. These models help distinguish pathogenic mutations from polymorphisms.
Knock-in
Knock-in of tagged or mutant alleles allows tracking of tRNA surveillance proteins and their interactions. Tagged knock-in models are used to study localization and dynamics of enzymes such as TRMT6. Disease-relevant knock-in mice model neurodegeneration caused by CLP1 mutations.
Overexpression
Overexpression of tRNA surveillance genes, such as ANG or TRMT6, is used to test gain-of-function effects on tRNA fragment production and translation. Overexpression models complement knockout studies to establish causality.
How EDITGENE Supports tRNA surveillance Research
Researchers studying tRNA surveillance-related genes often need to determine whether a candidate gene is causally involved in disease or whether its dysregulation is a consequence of other perturbations. CRISPR-based models provide the gold standard for such causal inference, enabling precise knockout, point-mutation, knock-in, and overexpression experiments in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for tRNA surveillance research.
Frequently Asked Questions About tRNA surveillance
What is tRNA surveillance?
tRNA surveillance (GO:0106354) is the set of processes that identify and degrade defective or aberrant tRNAs, maintaining translation fidelity.
What genes are involved in tRNA surveillance?
Key genes include TRMT6, TRMT61A, ANG, DICER1, AGO2, METTL1, WDR4, NSUN2, PUS7, DKC1, ELAC2, and CLP1, among others.
How is tRNA surveillance linked to cancer?
Dysregulation of tRNA modification and tRNA-derived fragments contributes to cancer progression and risk, with TRMT6 acting as a translational checkpoint in colorectal cancer.
What are tRNA-derived fragments?
tRNA-derived fragments (tRFs) and tsRNAs are small RNAs produced during tRNA surveillance and degradation, with regulatory roles in gene expression and cancer.
Can tRNA surveillance be studied with CRISPR?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are used to dissect causal roles of tRNA surveillance genes.
What diseases are associated with tRNA surveillance defects?
Cancer, neurological diseases, metabolic disorders, and ribosomopathies have been linked to tRNA surveillance defects.
How does amino acid availability affect tRNA surveillance?
Higher-order tRNA-mRNA interactions mediate amino acid surveillance, allowing the translation machinery to sense tRNA charging status.
What is the role of TRMT6 in tRNA surveillance?
TRMT6 catalyzes tRNA m1A modification, which acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression.
Are tRNA fragments useful as biomarkers?
Yes, circulating tRNA fragments can be detected in liquid biopsy and have been associated with neurological diseases and cancer.
How does epigenetic inheritance relate to tRNA surveillance?
Sperm-borne mitochondrial RNAs mediate epigenetic inheritance of diet-induced traits, linking tRNA surveillance to transgenerational effects.
Conclusion
tRNA surveillance (GO:0106354) is a fundamental quality-control process that identifies and degrades defective tRNAs, safeguarding translation and cellular homeostasis. Its dysregulation is increasingly implicated in cancer, neurological disease, and metabolic disorders, with tRNA modifications and tRNA-derived fragments serving as key effectors and biomarkers. CRISPR-based models and advanced sequencing methods are essential for dissecting the causal roles of tRNA surveillance genes and for developing targeted therapies. Continued research into this pathway promises to uncover new diagnostic and therapeutic opportunities across multiple disease areas.
References
- 1. Malhotra S et al.. 2023. Liquid Biopsy in Neurological Diseases.. Cells 12(14) PMID: 37508574
- 2. Tao EW et al.. 2025. TRMT6-mediated tRNA m(1)A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression.. Nat Cancer 6(8):1458-1476 PMID: 40461825
- 3. Tomar A et al.. 2024. Epigenetic inheritance of diet-induced and sperm-borne mitochondrial RNAs.. Nature 630(8017):720-727 PMID: 38839949
- 4. Lapinaite A et al.. 2020. DNA capture by a CRISPR-Cas9-guided adenine base editor.. Science 369(6503):566-571 PMID: 32732424
- 5. Tian Y et al.. 2025. Functional and clinical validation of tsRNA-defined molecular subtypes guides precision therapy in gastric cancer.. Front Immunol 16:1684113 PMID: 41256856
- 7. Li B et al.. 2025. Genetic Control of tRNA-Derived Fragments Contributes to Cancer Risk.. Cancer Res 85(20):3855-3874 PMID: 40773675
- 8. Li S et al.. 2019. Structural basis of amino acid surveillance by higher-order tRNA-mRNA interactions.. Nat Struct Mol Biol 26(12):1094-1105 PMID: 31740854
